Fabian Wild
Associate | Attorney at law
T. +41 58 510 92 11
fabian.wild@advestra.ch
vCard
Fabian Wild’s practice focuses on M&A, capital market and financing transactions. In addition, he advises companies on corporate and securities laws as well as employment law matters.
A specific focus of Fabian’s work is on advising foreign and domestic private and public companies as well as private equity and other investors on acquisitions and disposals, investments, joint ventures and other M&A transactions.
He further advises banks and issuers on a broad range of capital market transactions, including IPOs, capital increases and debt capital instruments, as well as on securities laws.
Capital Markets
- Advising Ares Management Corporation on its add-on investment in Peach Property Group AG by subscribing for CHF 50 million mandatory convertible bonds
- Advising Joincare Pharmaceutical Group Industry Co., Ltd. on its GDR offering and listing on SIX Swiss Exchange
- Advising the banking syndicate on the GDR offering and listing on SIX Swiss Exchange of Lepu Medical Technology (Beijing) Co., Ltd.
- Advising Keda Industrial Group and Ningbo Shanshan on their GDR offerings and listings on SIX Swiss Exchange
M&A
- Advising Cactus Life Sciences on the acquisition of nspm and eluSCIdate
- Advising funds affiliated with Perceptive Advisors on the acquisition of a portfolio of preclinical assets and launch of Neurosterix
- Advising Ironwood Pharmaceuticals on its public tender offer for VectivBio
- Advising Monte Valle Partners on the acquisition of TradeXBank Ltd.
- Associate at Advestra (since 2022)
- Admitted to the Bar of the canton of Zurich (2022)
- Secondment at Swiss telecommunications provider (2021)
- Junior associate at Bär & Karrer (2019–2020)
- Student employee at Bär & Karrer (2013-2019)
- MLaw at University of Zurich (2019)
- Semester abroad (SEMP) at University of Lund, Sweden (2018)
- BLaw at University of Zurich (2016)
- Zurich Bar Association (ZAV)
- UZH Alumni / UZH Alumni ius
- German
- English
- All Swiss Courts
- Advestra advises Breitling on the acquisition of Gallet
- Advestra advises LPSO Holding on the public tender offer for Orascom Development Holding
- Advestra advises Liberta Partners on the acquisition of a majority stake in Avenir
- Advestra advises ENR Russia Invest SA on the public tender offer of its majority shareholder Valartis
- Advestra advises Liberta Partners on the acquisition of DeinDeal
- Advestra advises Sequotech on its strategic partnership with EVOK
- Advestra advises UBS on EUR 300 million rights offering by Swiss Steel
- Advestra advises Cactus Life Sciences on the acquisition of nspm and eluSCIdate
- Advestra advises on the rights offering by Meyer Burger
- Advestra advises funds affiliated with Perceptive Advisors on the launch of Neurosterix